Healthcare Contract Development And Manufacturing Organization Market by Service Type (Contract Development Services, Contract Manufacturing Services), Product Type (Small Molecules, Large Molecules/Biologics), End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Medical Device Companies, Academic and Research Institutes), Therapeutic Area (Oncology, Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Infectious Diseases, Metabolic Disorders), & Region for 2024-2031
Report ID: 39444|No. of Pages: 202
Healthcare Contract Development And Manufacturing Organization Market by Service Type (Contract Development Services, Contract Manufacturing Services), Product Type (Small Molecules, Large Molecules/Biologics), End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Medical Device Companies, Academic and Research Institutes), Therapeutic Area (Oncology, Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Infectious Diseases, Metabolic Disorders), & Region for 2024-2031
Healthcare Contract Development And Manufacturing Organization Market Valuation – 2024-2031
The increasing outsourcing of pharmaceutical development and manufacturing processes has been driven by rising demand for cost-effective production solutions within the healthcare industry. According to the analyst from Verified Market Research, the Healthcare Contract Development And Manufacturing Organization Market is estimated to reach a valuation of USD 411.33 Billion over the forecast subjugating around USD 219.13 Billion valued in 2024.
The rapid expansion of the healthcare contract development and manufacturing organization market is primarily driven by the increasing focus on personalized medicine and the growing need for specialized drug development, which necessitates tailored manufacturing processes to meet diverse patient requirements. It enables the market to grow at a CAGR of 8.19% from 2024 to 2031.
Healthcare Contract Development And Manufacturing Organization Market: Definition/ Overview
Healthcare contract development and manufacturing organizations (CDMOs) are specialized firms that provide comprehensive services for pharmaceutical and biotechnology companies, encompassing drug development, manufacturing, and packaging solutions. These organizations are utilized to streamline production processes and enhance the efficiency of bringing drugs to market, allowing clients to focus on core competencies while ensuring regulatory compliance and quality assurance.
Increasing demand for innovative therapies and biologics is driving the growth of the Healthcare CDMO market. As the pharmaceutical industry faces pressure to reduce costs and improve time-to-market, the reliance on CDMOs is expected to rise, facilitating more efficient operations and enabling companies to adapt quickly to changing market needs.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=39444
How will the Increasing Demand for Personalized Medicine Impact the Healthcare Contract Development and Manufacturing Organization Market?
The impact of the increasing demand for personalized medicine on the healthcare contract development and manufacturing organization market is significant. It has been observed that a shift towards customized therapies is driving the need for specialized manufacturing capabilities that can accommodate varied patient profiles. According to VMR, Personalized Medicine Market size was valued at USD 305 Billion in 2023 and is projected to reach USD 490.1 Billion by 2030, growing at a CAGR of 8% during the forecast period 2024-2030.
By leveraging advanced technologies and innovative production methods, CDMOs are being positioned to meet these specific requirements efficiently. As a result, an expansion in service offerings tailored to personalized medicine has been noted, enabling clients to bring targeted treatments to market more rapidly while ensuring compliance with regulatory standards.
Furthermore, the increasing demand for personalized medicine is significantly impacting the healthcare contract development and manufacturing organization (CDMO) market, driven in part by initiatives such as the U.S. National Institutes of Health (NIH) Precision Medicine Initiative launched in 2015 with an initial investment of USD 215 Million.
How is the Growing Regulatory Complexity Influencing the Operational Strategies of Healthcare Contract Development and Manufacturing Organizations?
The influence of growing regulatory complexity on the operational strategies of healthcare contract development and manufacturing organizations is profound. It has been recognized that stringent guidelines and evolving regulations are necessitating the implementation of robust quality management systems and compliance protocols within CDMOs.
This situation is leading to increased investment in training and resources to ensure adherence to regulatory requirements. Furthermore, partnerships with regulatory experts are being established to navigate the intricate landscape, thus enhancing the ability of CDMOs to mitigate risks and maintain high standards in manufacturing and development processes.
Category-Wise Acumens
What Factors are Driving the Rapid Growth of Contract Manufacturing Services within the Healthcare Contract Development and Manufacturing Organization Market?
According to VMR analyst, the rapid growth of contract manufacturing services within the healthcare contract development and manufacturing organization market is being driven by several factors. It has been noted that the rising need for efficient production capabilities among pharmaceutical and biotechnology companies is fueling this segment’s expansion. As companies aim to reduce costs and accelerate time-to-market for their products, the outsourcing of manufacturing processes to specialized CDMOs is being preferred.
Additionally, the complexity of modern drug formulations, particularly biologics and personalized medicines, requires advanced manufacturing techniques, further enhancing the reliance on contract manufacturing services. Consequently, a significant increase in market share for this segment has been observed, underscoring its critical role in the overall healthcare landscape.
How is the Increasing Demand for Oncology Therapies Influencing the Healthcare Contract Development and Manufacturing Organization Market?
According to VMR analyst, the increasing demand for oncology therapies is significantly influencing the therapeutic areas segment of the healthcare contract development and manufacturing organization market. It has been recognized that the prevalence of cancer and the need for innovative treatment options are driving investment in oncology-focused research and development. This trend is prompting CDMOs to enhance their capabilities in producing specialized therapies, including targeted and immunotherapies.
By expanding their service offerings to cater specifically to oncology, these organizations are being positioned to meet the unique requirements of pharmaceutical and biopharmaceutical companies. As a result, a rapid growth trajectory in this therapeutic area is being projected, indicating a robust opportunity for CDMOs to capitalize on emerging oncology treatments.
Gain Access into Healthcare Contract Development And Manufacturing Organization Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=39444
Country/Region-wise Acumens
What Key Factors are Driving the Dominance of North America in the Healthcare Contract Development and Manufacturing Organization Market?
According to VMR analyst, the dominance of North America in the healthcare contract development and manufacturing organization market is being driven by several key factors. It has been observed that a robust pharmaceutical and biotechnology sector, characterized by significant research and development activities, is propelling the demand for contract development and manufacturing services. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), biopharmaceutical companies invested an estimated USD 91.1 Billion in R&D in 2020 in the United States alone.
Furthermore, the presence of established healthcare infrastructure and advanced technology adoption are enhancing the capabilities of CDMOs in this region. Regulatory support and investment in innovative therapies, particularly in oncology and rare diseases, are also contributing to North America’s leading position. Consequently, a substantial market share is being captured by North American CDMOs, reflecting their crucial role in the global healthcare ecosystem.
How is the Growing Demand for Biopharmaceuticals Influencing the Healthcare Contract Development and Manufacturing Organization Market in the Asia Pacific Region?
According to VMR analyst, the growing demand for biopharmaceuticals is significantly influencing the healthcare contract development and manufacturing organization market in the Asia Pacific region. It has been recognized that increasing investments in healthcare infrastructure and the rising prevalence of chronic diseases are prompting pharmaceutical companies to seek specialized manufacturing solutions.
As a result, CDMOs in Asia Pacific are expanding their capabilities to produce complex biologics and personalized medicines. Additionally, favorable regulatory environments and government initiatives aimed at boosting local production are facilitating growth in this segment. This trend is expected to lead to rapid market expansion, positioning Asia Pacific as a key player in the global CDMO landscape.
Supportive government policies and investments in healthcare infrastructure are propelling the CDMO market in the Asia Pacific region. The Indian government’s ‘Pharma Vision 2020’ initiative seeks to position India as a global leader in comprehensive drug manufacturing. To support this goal, the government has permitted 100% Foreign Direct Investment (FDI) in the pharmaceutical sector through the automatic route.
Competitive Landscape
The Healthcare Contract Development And Manufacturing Organization Market’s competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.
Some of the prominent players operating in the healthcare contract development and manufacturing organization market include:
- AbbVie, Inc.
- Baxter International, Inc.
- Catalent, Inc.
- Covance, Inc.
- Flex
- IQVIA Holdings, Inc.
- Jabil
- Lonza Group Ltd.
- Pfizer, Inc.
- Recipharm AB
- Sanmina Corporation
- Siegfried Holding AG
- Thermo Fisher Scientific, Inc.
Latest Developments
- In March 2024, LGM Pharma revealed plans for a 50% expansion of its Analytical Testing Services (ATS) division, backed by an investment of over USD 2 million, which will include the addition of new suppository manufacturing capabilities to its contract development and manufacturing (CDMO) offerings.
- In September 2023, WuXi Vaccines announced the establishment of a vaccine CDMO facility in China. This new site is designed to enhance drug substance and drug product capacity, providing comprehensive end-to-end services for a variety of vaccines, thereby accelerating project timelines from process development to clinical-scale drug substance and small-to-medium sterile drug product manufacturing.
Report Scope
| Report Attributes | Details |
|---|---|
| Study Period | 2021-2031 |
| Growth Rate | CAGR of ~8.19% from 2024 to 2031 |
| Base Year for Valuation | 2024 |
| Historical Period | 2021-2023 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | AbbVie, Inc., Baxter International, Inc., Catalent, Inc., Covance, Inc., Flex, IQVIA Holdings, Inc., Jabil, Lonza Group Ltd., Pfizer, Inc., Recipharm AB, Sanmina Corporation, Siegfried Holding AG, Thermo Fisher Scientific, Inc. |
| Customization | Report customization along with purchase available upon request |
Healthcare Contract Development And Manufacturing Organization Market, By Category
Service Type:
- Contract Development Services
- Contract Manufacturing Services
Product Type:
- Small Molecules
- Large Molecules/Biologics
End-User:
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Medical Device Companies
- Academic and Research Institutes
Therapeutic Area:
- Oncology
- Cardiovascular Diseases
- Central Nervous System (CNS) Disorders
- Infectious Diseases
- Metabolic Disorders
Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET, BY SERVICE
5.1 Overview
5.2 Contract Development
5.3 Contract Manufacturing
6 GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET, BY GEOGRAPHY
6.1 Overview
6.2 North America
6.2.1 The U.S.
6.2.2 Canada
6.2.3 Mexico
6.3 Europe
6.3.1 Germany
6.3.2 The U.K.
6.3.3 France
6.3.4 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 India
6.4.4 Rest of Asia Pacific
6.5 Rest of the World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 GLOBAL HEALTHCARE CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION MARKET COMPETITIVE LANDSCAPE
7.1 Overview
7.2 Company Market Ranking
7.3 Key Development Strategies
8 COMPANY PROFILES
8.1 Catalent Inc.
8.1.1 Overview
8.1.2 Financial Performance
8.1.3 Product Outlook
8.1.4 Key Developments
8.2 Lonza Group Ltd.
8.2.1 Overview
8.2.2 Financial Performance
8.2.3 Product Outlook
8.2.4 Key Developments
8.3 Recipharm AB
8.3.1 Overview
8.3.2 Financial Performance
8.3.3 Product Outlook
8.3.4 Key Developments
8.4 Siegfried Holding AG
8.4.1 Overview
8.4.2 Financial Performance
8.4.3 Product Outlook
8.4.4 Key Developments
8.5 Thermo Fisher Scientific Inc.
8.5.1 Overview
8.5.2 Financial Performance
8.5.3 Product Outlook
8.5.4 Key Developments
8.6 Covance Inc.
8.6.1 Overview
8.6.2 Financial Performance
8.6.3 Product Outlook
8.6.4 Key Developments
8.7 Jabil
8.7.1 Overview
8.7.2 Financial Performance
8.7.3 Product Outlook
8.7.4 Key Developments
8.8 Sanmina Corporation
8.8.1 Overview
8.8.2 Financial Performance
8.8.3 Product Outlook
8.8.4 Key Developments
8.9 IQVIA Holdings Inc.
8.9.1 Overview
8.9.2 Financial Performance
8.9.3 Product Outlook
8.9.4 Key Developments
8.10 Flex
8.10.1 Overview
8.10.2 Financial Performance
8.10.3 Product Outlook
8.10.4 Key Developments
9 Appendix
9.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
Healthcare Contract Development And Manufacturing Organization Market
Download Sample Report